288 related articles for article (PubMed ID: 22882897)
1. Synthesis, in vitro biological evaluation and molecular docking studies of benzimidamides as potential BACE1 inhibitors.
Niu Y; Gao H; Xu F; Wang C; Liu P; Yang G; Sun Q; Xu P
Chem Biol Drug Des; 2012 Nov; 80(5):775-80. PubMed ID: 22882897
[TBL] [Abstract][Full Text] [Related]
2. The evolution of amidine-based brain penetrant BACE1 inhibitors.
Oehlrich D; Prokopcova H; Gijsen HJ
Bioorg Med Chem Lett; 2014 May; 24(9):2033-45. PubMed ID: 24704031
[TBL] [Abstract][Full Text] [Related]
3. BACE1 inhibitors: a head group scan on a series of amides.
Woltering TJ; Wostl W; Hilpert H; Rogers-Evans M; Pinard E; Mayweg A; Göbel M; Banner DW; Benz J; Travagli M; Pollastrini M; Marconi G; Gabellieri E; Guba W; Mauser H; Andreini M; Jacobsen H; Power E; Narquizian R
Bioorg Med Chem Lett; 2013 Jul; 23(14):4239-43. PubMed ID: 23735744
[TBL] [Abstract][Full Text] [Related]
4. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
[TBL] [Abstract][Full Text] [Related]
5. Pyridinyl aminohydantoins as small molecule BACE1 inhibitors.
Zhou P; Li Y; Fan Y; Wang Z; Chopra R; Olland A; Hu Y; Magolda RL; Pangalos M; Reinhart PH; Turner MJ; Bard J; Malamas MS; Robichaud AJ
Bioorg Med Chem Lett; 2010 Apr; 20(7):2326-9. PubMed ID: 20202842
[TBL] [Abstract][Full Text] [Related]
6. Carbazole-containing arylcarboxamides as BACE1 inhibitors.
Bertini S; Asso V; Ghilardi E; Granchi C; Manera C; Minutolo F; Saccomanni G; Bortolato A; Mason J; Moro S; Macchia M
Bioorg Med Chem Lett; 2011 Nov; 21(22):6657-61. PubMed ID: 21986588
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
[TBL] [Abstract][Full Text] [Related]
8. Novel pyrrolyl 2-aminopyridines as potent and selective human beta-secretase (BACE1) inhibitors.
Malamas MS; Barnes K; Hui Y; Johnson M; Lovering F; Condon J; Fobare W; Solvibile W; Turner J; Hu Y; Manas ES; Fan K; Olland A; Chopra R; Bard J; Pangalos MN; Reinhart P; Robichaud AJ
Bioorg Med Chem Lett; 2010 Apr; 20(7):2068-73. PubMed ID: 20223661
[TBL] [Abstract][Full Text] [Related]
9. Phenylimino-2H-chromen-3-carboxamide derivatives as novel small molecule inhibitors of β-secretase (BACE1).
Edraki N; Firuzi O; Foroumadi A; Miri R; Madadkar-Sobhani A; Khoshneviszadeh M; Shafiee A
Bioorg Med Chem; 2013 Apr; 21(8):2396-2412. PubMed ID: 23480856
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer's disease.
Haghighijoo Z; Firuzi O; Hemmateenejad B; Emami S; Edraki N; Miri R
Bioorg Chem; 2017 Oct; 74():126-133. PubMed ID: 28780149
[TBL] [Abstract][Full Text] [Related]
11. Oleic acid and linoleic acid from Tenebrio molitor larvae inhibit BACE1 activity in vitro: molecular docking studies.
Youn K; Yun EY; Lee J; Kim JY; Hwang JS; Jeong WS; Jun M
J Med Food; 2014 Feb; 17(2):284-9. PubMed ID: 24548007
[TBL] [Abstract][Full Text] [Related]
12. From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1).
Cheng Y; Judd TC; Bartberger MD; Brown J; Chen K; Fremeau RT; Hickman D; Hitchcock SA; Jordan B; Li V; Lopez P; Louie SW; Luo Y; Michelsen K; Nixey T; Powers TS; Rattan C; Sickmier EA; St Jean DJ; Wahl RC; Wen PH; Wood S
J Med Chem; 2011 Aug; 54(16):5836-57. PubMed ID: 21707077
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors.
Liu J; Chen W; Xu Y; Ren S; Zhang W; Li Y
Bioorg Med Chem; 2015 May; 23(9):1963-74. PubMed ID: 25842365
[TBL] [Abstract][Full Text] [Related]
14. Discovery of biphenylacetamide-derived inhibitors of BACE1 using de novo structure-based molecular design.
Mok NY; Chadwick J; Kellett KA; Casas-Arce E; Hooper NM; Johnson AP; Fishwick CW
J Med Chem; 2013 Mar; 56(5):1843-52. PubMed ID: 23374014
[TBL] [Abstract][Full Text] [Related]
15. Piperazine sulfonamide BACE1 inhibitors: design, synthesis, and in vivo characterization.
Cumming J; Babu S; Huang Y; Carrol C; Chen X; Favreau L; Greenlee W; Guo T; Kennedy M; Kuvelkar R; Le T; Li G; McHugh N; Orth P; Ozgur L; Parker E; Saionz K; Stamford A; Strickland C; Tadesse D; Voigt J; Zhang L; Zhang Q
Bioorg Med Chem Lett; 2010 May; 20(9):2837-42. PubMed ID: 20347593
[TBL] [Abstract][Full Text] [Related]
16. Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor.
Cumming JN; Smith EM; Wang L; Misiaszek J; Durkin J; Pan J; Iserloh U; Wu Y; Zhu Z; Strickland C; Voigt J; Chen X; Kennedy ME; Kuvelkar R; Hyde LA; Cox K; Favreau L; Czarniecki MF; Greenlee WJ; McKittrick BA; Parker EM; Stamford AW
Bioorg Med Chem Lett; 2012 Apr; 22(7):2444-9. PubMed ID: 22390835
[TBL] [Abstract][Full Text] [Related]
17. 2-Substituted-thio-N-(4-substituted-thiazol/1H-imidazol-2-yl)acetamides as BACE1 inhibitors: Synthesis, biological evaluation and docking studies.
Yan G; Hao L; Niu Y; Huang W; Wang W; Xu F; Liang L; Wang C; Jin H; Xu P
Eur J Med Chem; 2017 Sep; 137():462-475. PubMed ID: 28624701
[TBL] [Abstract][Full Text] [Related]
18. Regulation of proBACE1 by glycosaminoglycans.
Small DH; Klaver DW; Beckman M
Neurodegener Dis; 2008; 5(3-4):206-8. PubMed ID: 18322391
[TBL] [Abstract][Full Text] [Related]
19. N-(2-(Piperazin-1-yl)phenyl)arylamide Derivatives as β-Secretase (BACE1) Inhibitors: Simple Synthesis by Ugi Four-Component Reaction and Biological Evaluation.
Edraki N; Firuzi O; Fatahi Y; Mahdavi M; Asadi M; Emami S; Divsalar K; Miri R; Iraji A; Khoshneviszadeh M; Firoozpour L; Shafiee A; Foroumadi A
Arch Pharm (Weinheim); 2015 May; 348(5):330-7. PubMed ID: 25787800
[TBL] [Abstract][Full Text] [Related]
20. Conformational restriction approach to β-secretase (BACE1) inhibitors: effect of a cyclopropane ring to induce an alternative binding mode.
Yonezawa S; Yamamoto T; Yamakawa H; Muto C; Hosono M; Hattori K; Higashino K; Yutsudo T; Iwamoto H; Kondo Y; Sakagami M; Togame H; Tanaka Y; Nakano T; Takemoto H; Arisawa M; Shuto S
J Med Chem; 2012 Oct; 55(20):8838-58. PubMed ID: 22998419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
